Delivery Order SPE2DB22D2005-SPE2DB25FJPD7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order valued at $21,534.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 unit vials, with an ultimate completion date of July 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a direct order fulfillment under the vendor's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $42,739.50 to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials, with a completion date of August 20, 2025. This competitive award, issued on July 30, 2025, carries no set-aside designation and employs firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $30,112.50 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $20,514.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with a completion date of July 22, 2025. This competitive award, with no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Botox 200 Unit Vials with a ceiling value of $25,643.70 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 17, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJPD7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,772.44 to AmerisourceBergen Drug Corp for the supply of Botox 200 Unit Vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 21, 2025, and involves no set-aside designation. The award was made on June 27, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency and other government healthcare systems through its extensive product portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support enabling the company to supply a wide range of medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The firm's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its significant IDC vehicle, positions it as a key provider within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 6/27/25 |